EKSO

Ekso Bionics Holdings, Inc. (EKSO) | Rumor.io

Ekso Bionics Holdings

EKSO

Attention (50-day avg)0%

Attention rank (50-day avg)#2,046

Bullish sentiment (50-day avg)46%

Price to earnings ratio-4.04

Market capitalization70.7M

Earnings per share-5.11

Dividend yield (TTM)—

Revenue (annual)12.8M

Net income (annual)-11.7M

Social

What share of all stock conversation is about EKSO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

Feb 18

$EKSO has been quietly moving into the top 3 positions in a smart money portfolio, with a 30% gain.
Ekso Bionics is transforming into a positive future, with analyst ratings as high as $49.00 and potential for significant growth.
The company is commercializing robotics and exoskeleton tech, with a critical pace of commercialization expected to drive further growth.

Generated by AI

Sentiment

Of the messages about EKSO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	65.4% +5.16
Bearish	—	—	—	34.6% -5.16

Bullish· Jan 6

$EKSO has seen its biggest monthly buy volume in over 4 years, suggesting a strong rally is underway.
Ekso Bionics Holdings, Inc. has the potential to push up over $12 by Friday, based on current trends.
The company is well-positioned for a squeeze play, with a decent amount of volume and shorts expected to be squeezed out.

Bearish· Jan 2

Ekso Bionics Holdings, Inc. ($EKSO) is being used as a shell to list Applied Digital's business and raise capital, with Ekso only receiving 3% of the newly formed company.
The company has a significant burn rate of $2 million per quarter and only has enough cash to last for a short period, with some estimates suggesting only days of capital left.
Ekso's shares are considered worthless, with some analysts predicting a price drop to $5.50 or below, and the company's history of not being profitable and burning cash every quarter is seen as a major red flag.

Generated by AI

Topics

Of the messages about EKSO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Controversies	—	—	—	1.94%
Analysts	—	—	—	11.61%
Announcements	—	—	—	47.8%
Earnings	—	—	—	0.1%
Macro	—	—	—	10.11%
Technical Analysis	—	—	—	28.45%

Earnings· Aug 7

Ekso Bionics Holdings, Inc. released Q2 earnings after close on August 7.
The company missed earnings expectations by $0.02 and revenue expectations.
Ekso Bionics Holdings has a backlog of orders that were not included in Q2 sales.

Announcements· Dec 31

Ekso Bionics Holdings, Inc. ($EKSO) is pivoting its business from medical exoskeletons to AI infrastructure, combining with Applied Digital's cloud unit to form ChronoScale.
The proposed business combination aims to establish an accelerated compute platform for AI workloads, leveraging high-performance GPU infrastructure to cater to growing demand for cloud infrastructure.
Ekso Bionics' shares surged 90%+ following the announcement, targeting a key breakout at $20 resistance, with the company set to raise $200-500 million through an IPO to fund the new venture.

Technical Analysis· Dec 31

$EKSO formed a double top on the chart, indicating a bearish reversal and a potential price drop.
The stock's price action is showing a "Step-wise" downward movement, which may be poised for a reversal if it can get inside the Blue Zone.
$EKSO is currently in a consolidation phase after a significant price expansion, and its trading structure indicates that it may be preparing for further upward movement.

Generated by AI

Community

Of the messages about EKSO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	37.75%
Newcomers	100%	100%	100%	62.25%

Regulars· Dec 30

$EKSO is expected to continue its uptrend, potentially reaching new highs after a merger announcement with Applied Digital.
The proposed merger with Applied Digital is expected to form ChronoScale, an accelerated GPU compute platform for AI workloads, which could lead to a significant increase in the stock's value.
The technical breakout of $EKSO on high volume, with RSI indicating strong momentum, suggests that the stock is poised for further gains.

Newcomers· Dec 31

$EKSO's recent 60% surge is not due to its medical exoskeleton business, but rather a proposed merger with Applied Digital's cloud business, forming "ChronoScale" that could unlock a $600 billion AI Cloud opportunity.
Ekso Bionics is effectively selling off its legacy medical business to focus on this new AI Cloud opportunity, which already generated $75 million in revenue last year.
The merger news has led to a 94% pop in $EKSO's stock price, with many seeing this as a potential entry point into the AI computing and digital infrastructure space.

Generated by AI

Also Discussed

Investors talking about EKSO also mention

#	Name	Attention
1	Lifeward Ltd.LFWD	0%new
2	Myomo Inc.MYO	0%0
3	MRNS - Marinus Pharmaceuticals, Inc.	——
4	YTEN - Yield10 Bioscience, Inc.	——
5	Daxor CorporationDXR	0%0
6	RWLK - ReWalk Robotics Ltd.	——
7	A SPAC III Acquisition Corp. Class A Ordinary SharesASPC	0%0
8	Esh Acquisition Corp.ESHA	0%0
9	BIO-key International, Inc.BKYI	0.08%+0.08
10	Avalon Holdings Corp. Class A Common StockAWX	0%new

Ekso Bionics Holdings, Inc.

Healthcare
Medical Instruments & Supplies

Ekso Bionics Holdings, Inc. is a pioneering robotics company specializing in the development and commercialization of powered exoskeletons, wearable robotic devices designed to enhance human mobility, strength, and endurance. Founded in 2005, Ekso Bionics primarily serves medical rehabilitation and industrial sectors by offering innovative technologies that enable individuals with lower extremity weakness or paralysis—such as those affected by spinal cord injuries, stroke, or multiple sclerosis—to stand and walk with assistance. Their product portfolio includes advanced exoskeleton systems like EksoNR for neurorehabilitation and Indego Personal for personal mobility, as well as industrial exoskeletons that support workers performing physically demanding tasks. The company integrates adaptive software and sensor technologies to provide customizable support and track patient progress, contributing significantly to advancements in human mobility and workplace injury reduction. Headquartered in Northern California, Ekso Bionics continues to lead in exoskeleton technology, merging robotics and healthcare to improve quality of life and worker capability worldwide.

Website

Location

101 Glacier Point

San Rafael, CA, 94901

United States

Social

What share of all stock conversation is about EKSO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

Feb 18

$EKSO has been quietly moving into the top 3 positions in a smart money portfolio, with a 30% gain.
Ekso Bionics is transforming into a positive future, with analyst ratings as high as $49.00 and potential for significant growth.
The company is commercializing robotics and exoskeleton tech, with a critical pace of commercialization expected to drive further growth.

Generated by AI

Sentiment

Of the messages about EKSO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	65.4% +5.16
Bearish	—	—	—	34.6% -5.16

Bullish· Jan 6

$EKSO has seen its biggest monthly buy volume in over 4 years, suggesting a strong rally is underway.
Ekso Bionics Holdings, Inc. has the potential to push up over $12 by Friday, based on current trends.
The company is well-positioned for a squeeze play, with a decent amount of volume and shorts expected to be squeezed out.

Bearish· Jan 2

Ekso Bionics Holdings, Inc. ($EKSO) is being used as a shell to list Applied Digital's business and raise capital, with Ekso only receiving 3% of the newly formed company.
The company has a significant burn rate of $2 million per quarter and only has enough cash to last for a short period, with some estimates suggesting only days of capital left.
Ekso's shares are considered worthless, with some analysts predicting a price drop to $5.50 or below, and the company's history of not being profitable and burning cash every quarter is seen as a major red flag.

Generated by AI

Topics

Of the messages about EKSO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Controversies	—	—	—	1.94%
Analysts	—	—	—	11.61%
Announcements	—	—	—	47.8%
Earnings	—	—	—	0.1%
Macro	—	—	—	10.11%
Technical Analysis	—	—	—	28.45%

Earnings· Aug 7

Ekso Bionics Holdings, Inc. released Q2 earnings after close on August 7.
The company missed earnings expectations by $0.02 and revenue expectations.
Ekso Bionics Holdings has a backlog of orders that were not included in Q2 sales.

Announcements· Dec 31

Ekso Bionics Holdings, Inc. ($EKSO) is pivoting its business from medical exoskeletons to AI infrastructure, combining with Applied Digital's cloud unit to form ChronoScale.
The proposed business combination aims to establish an accelerated compute platform for AI workloads, leveraging high-performance GPU infrastructure to cater to growing demand for cloud infrastructure.
Ekso Bionics' shares surged 90%+ following the announcement, targeting a key breakout at $20 resistance, with the company set to raise $200-500 million through an IPO to fund the new venture.

Technical Analysis· Dec 31

$EKSO formed a double top on the chart, indicating a bearish reversal and a potential price drop.
The stock's price action is showing a "Step-wise" downward movement, which may be poised for a reversal if it can get inside the Blue Zone.
$EKSO is currently in a consolidation phase after a significant price expansion, and its trading structure indicates that it may be preparing for further upward movement.

Generated by AI

Community

Of the messages about EKSO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	37.75%
Newcomers	100%	100%	100%	62.25%

Regulars· Dec 30

$EKSO is expected to continue its uptrend, potentially reaching new highs after a merger announcement with Applied Digital.
The proposed merger with Applied Digital is expected to form ChronoScale, an accelerated GPU compute platform for AI workloads, which could lead to a significant increase in the stock's value.
The technical breakout of $EKSO on high volume, with RSI indicating strong momentum, suggests that the stock is poised for further gains.

Newcomers· Dec 31

$EKSO's recent 60% surge is not due to its medical exoskeleton business, but rather a proposed merger with Applied Digital's cloud business, forming "ChronoScale" that could unlock a $600 billion AI Cloud opportunity.
Ekso Bionics is effectively selling off its legacy medical business to focus on this new AI Cloud opportunity, which already generated $75 million in revenue last year.
The merger news has led to a 94% pop in $EKSO's stock price, with many seeing this as a potential entry point into the AI computing and digital infrastructure space.

Generated by AI

Ekso Bionics Holdings

Social

Feb 18

Sentiment

Bullish· Jan 6

Bearish· Jan 2

Topics

Earnings· Aug 7

Announcements· Dec 31

Technical Analysis· Dec 31

Community

Regulars· Dec 30

Newcomers· Dec 31

Also Discussed

Ekso Bionics Holdings, Inc.

Company Information

Location

Also Discussed

Social

Feb 18

Sentiment

Bullish· Jan 6

Bearish· Jan 2

Topics

Earnings· Aug 7

Announcements· Dec 31

Technical Analysis· Dec 31

Community

Regulars· Dec 30

Newcomers· Dec 31